• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Tata Power Company Ltd
Industry :  Power Generation And Supply
BSE Code
ISIN Demat
Book Value()
500400
INE245A01021
58.5135748
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATAPOWER
95.03
109919.68
EPS(TTM)
Face Value()
Div & Yield %
3.62
1
0.73
 

modern engineering & projects limited
Fredun Pharmaceuticals surges after Q1 PAT rises 94% YoY to Rs 13 crore
Aug 05,2026

Revenue from operations rose by 90.7% year-on-year (YoY) to Rs 227.75 crore during the period under review.

Total expenses rose by 86.6% to Rs 206.79 crore in Q1 FY27 from Rs 110.81 crore in Q1 FY26. This was primarily due to higher raw material costs (up 97.6% YoY), higher depreciation charges (up 151.6% YoY) and higher other expenses (up 52.5% YoY).

Profit before tax in Q1 FY27 stood at Rs 20.55 crore, up 127.3% from Rs 9.04 crore in Q1 FY26.

Fredun Pharmaceuticals manufactures pharmaceutical formulations such as tablets, syrups, capsules, and ointments. The company's product basket includes multiple therapeutic classes such as anti-diabetics, anti-retroviral, anti-hypertensive etc.